Diagnostic Advances: Innovative Techniques and Biomarkers for Prostate Cancer Diagnosis

Prostate cancer (PC) is a heterogeneous complex neoplastic malignancy that is continuously contributing to high death rates among men. The complexity of PC can be attributed to challenges linked to both treatment strategies; and most importantly, the lack of routinely used sensitive diagnostic tools for early detection. As a prevalent malignancy, PC affects men, globally, with early diagnosis being of paramount importance. Therefore, the development of novel and innovative strategies for diagnosis is vital. Although PC is likely to represent a substantial element in Africa’s total cancer burden, less is known among the sub-Saharan Africa (SSA) population regarding screening, detection, diagnosis, and treatment methods for PC. This chapter explores recent advancements to ameliorate the accuracy and efficiency of PC diagnosis. By examining innovative techniques and emerging biomarkers, it seeks to shed light on the current landscape of PC diagnostics and the potential for precise, noninvasive, and personalized approaches.